AstraZeneca advances plan for climate-friendly inhalers
Business Green
FEBRUARY 22, 2022
per cent less Global Warming Potential (GWP) than propellants currently used in respiratory medicines. AstraZeneca said it now expects Breztri to be its first medicine to transition to the new near-zero climate impact inhaler, subject to regulatory approval. Want to help celebrate and showcase the best of the green economy?
Let's personalize your content